The bill aims to make prescription drug pricing more transparent and prevent PBMs or consultants from misleading employers about cheaper, lawful alternatives. It requires PBMs to share drug cost data on request, imposes penalties for repeated violations, and supports programs that help contain prescription drug costs.
